학술논문

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results from a randomised, phase 2 study
Document Type
Article
Source
In: Journal of Crohn's and Colitis. (Journal of Crohn's and Colitis, 9 November 2018, 12(10):1158-1169)
Subject
Language
English
ISSN
18764479
18739946